135 related articles for article (PubMed ID: 23457529)
1. Altered prostanoid signaling contributes to increased skin tumorigenesis in Tpl2 knockout mice.
DeCicco-Skinner KL; Nolan SJ; Deshpande MM; Trovato EL; Dempsey TA; Wiest JS
PLoS One; 2013; 8(2):e56212. PubMed ID: 23457529
[TBL] [Abstract][Full Text] [Related]
2. Loss of tumor progression locus 2 (tpl2) enhances tumorigenesis and inflammation in two-stage skin carcinogenesis.
Decicco-Skinner KL; Trovato EL; Simmons JK; Lepage PK; Wiest JS
Oncogene; 2011 Jan; 30(4):389-97. PubMed ID: 20935675
[TBL] [Abstract][Full Text] [Related]
3. Tpl2 knockout keratinocytes have increased biomarkers for invasion and metastasis.
Decicco-Skinner KL; Jung SA; Tabib T; Gwilliam JC; Alexander H; Goodheart SE; Merchant AS; Shan M; Garber C; Wiest JS
Carcinogenesis; 2013 Dec; 34(12):2789-98. PubMed ID: 24067898
[TBL] [Abstract][Full Text] [Related]
4. The Tpl2 Kinase Regulates the COX-2/Prostaglandin E2 Axis in Adipocytes in Inflammatory Conditions.
Berthou F; Ceppo F; Dumas K; Massa F; Vergoni B; Alemany S; Cormont M; Tanti JF
Mol Endocrinol; 2015 Jul; 29(7):1025-36. PubMed ID: 26020725
[TBL] [Abstract][Full Text] [Related]
5. Tpl2 is a key mediator of arsenite-induced signal transduction.
Lee KM; Lee KW; Bode AM; Lee HJ; Dong Z
Cancer Res; 2009 Oct; 69(20):8043-9. PubMed ID: 19808956
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of TPA-induced cyclooxygenase-2 (COX-2) expression by apigenin through downregulation of Akt signal transduction in human keratinocytes.
Van Dross RT; Hong X; Pelling JC
Mol Carcinog; 2005 Oct; 44(2):83-91. PubMed ID: 16044407
[TBL] [Abstract][Full Text] [Related]
7. Induction of COX-2 by LPS in macrophages is regulated by Tpl2-dependent CREB activation signals.
Eliopoulos AG; Dumitru CD; Wang CC; Cho J; Tsichlis PN
EMBO J; 2002 Sep; 21(18):4831-40. PubMed ID: 12234923
[TBL] [Abstract][Full Text] [Related]
8. Loss of Tpl2 activates compensatory signaling and resistance to EGFR/MET dual inhibition in v-RAS transduced keratinocytes.
Kelley MB; Geddes TJ; Ochiai M; Lampl NM; Kothmann WW; Fierstein SR; Kent V; DeCicco-Skinner K
PLoS One; 2022; 17(3):e0266017. PubMed ID: 35325006
[TBL] [Abstract][Full Text] [Related]
9. Tpl2 regulates intestinal myofibroblast HGF release to suppress colitis-associated tumorigenesis.
Koliaraki V; Roulis M; Kollias G
J Clin Invest; 2012 Nov; 122(11):4231-42. PubMed ID: 23064365
[TBL] [Abstract][Full Text] [Related]
10. Resveratrol modulates phorbol ester-induced pro-inflammatory signal transduction pathways in mouse skin in vivo: NF-kappaB and AP-1 as prime targets.
Kundu JK; Shin YK; Surh YJ
Biochem Pharmacol; 2006 Nov; 72(11):1506-15. PubMed ID: 16999939
[TBL] [Abstract][Full Text] [Related]
11. Tpl2 kinase regulates inflammation but not tumorigenesis in mice.
Wu KC; Cain G; Corpuz J; Xu D; Ljumanovic N; Zarrin AA
Toxicol Appl Pharmacol; 2021 May; 418():115494. PubMed ID: 33722668
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-17 induces AP-1 activity and cellular transformation via upregulation of tumor progression locus 2 activity.
Kim G; Khanal P; Lim SC; Yun HJ; Ahn SG; Ki SH; Choi HS
Carcinogenesis; 2013 Feb; 34(2):341-50. PubMed ID: 23125217
[TBL] [Abstract][Full Text] [Related]
13. Protein kinase C-alpha coordinately regulates cytosolic phospholipase A(2) activity and the expression of cyclooxygenase-2 through different mechanisms in mouse keratinocytes.
Wang HQ; Kim MP; Tiano HF; Langenbach R; Smart RC
Mol Pharmacol; 2001 Apr; 59(4):860-6. PubMed ID: 11259631
[TBL] [Abstract][Full Text] [Related]
14. Celecoxib inhibits phorbol ester-induced expression of COX-2 and activation of AP-1 and p38 MAP kinase in mouse skin.
Chun KS; Kim SH; Song YS; Surh YJ
Carcinogenesis; 2004 May; 25(5):713-22. PubMed ID: 14729583
[TBL] [Abstract][Full Text] [Related]
15. TPL2 kinase is a suppressor of lung carcinogenesis.
Gkirtzimanaki K; Gkouskou KK; Oleksiewicz U; Nikolaidis G; Vyrla D; Liontos M; Pelekanou V; Kanellis DC; Evangelou K; Stathopoulos EN; Field JK; Tsichlis PN; Gorgoulis V; Liloglou T; Eliopoulos AG
Proc Natl Acad Sci U S A; 2013 Apr; 110(16):E1470-9. PubMed ID: 23533274
[TBL] [Abstract][Full Text] [Related]
16. Tpl2 kinase impacts tumor growth and metastasis of clear cell renal cell carcinoma.
Lee HW; Joo KM; Lim JE; Cho HJ; Cho HJ; Park MC; Seol HJ; Seo SI; Lee JI; Kim S; Jeong BC; Nam DH
Mol Cancer Res; 2013 Nov; 11(11):1375-86. PubMed ID: 23982215
[TBL] [Abstract][Full Text] [Related]
17. Tumor progression locus 2 (TPL2) in tumor-promoting Inflammation, Tumorigenesis and Tumor Immunity.
Njunge LW; Estania AP; Guo Y; Liu W; Yang L
Theranostics; 2020; 10(18):8343-8364. PubMed ID: 32724474
[TBL] [Abstract][Full Text] [Related]
18. Tumor progression locus 2 (Map3k8) is critical for host defense against Listeria monocytogenes and IL-1 beta production.
Mielke LA; Elkins KL; Wei L; Starr R; Tsichlis PN; O'Shea JJ; Watford WT
J Immunol; 2009 Dec; 183(12):7984-93. PubMed ID: 19933865
[TBL] [Abstract][Full Text] [Related]
19. Tumor progression locus 2 ablation suppressed hepatocellular carcinoma development by inhibiting hepatic inflammation and steatosis in mice.
Li X; Liu C; Ip BC; Hu KQ; Smith DE; Greenberg AS; Wang XD
J Exp Clin Cancer Res; 2015 Nov; 34():138. PubMed ID: 26560698
[TBL] [Abstract][Full Text] [Related]
20. Tumor progression locus 2 (Tpl2) deficiency does not protect against obesity-induced metabolic disease.
Lancaster GI; Kowalski GM; Estevez E; Kraakman MJ; Grigoriadis G; Febbraio MA; Gerondakis S; Banerjee A
PLoS One; 2012; 7(6):e39100. PubMed ID: 22701749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
